drugset / Trial / NCT03878628
Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to assess the safety and feasibility of allogeneic adipose tissue-derived mesenchymal stem cells (ASCs) injected into the lacrimal gland in a smaller groups of 7 patients with Aqueous Deficient Dry Eye Disease (ADDE)
Timeline
- Start
- 2019-10-16
- Primary completion
- 2020-06-30
- Completion
- 2023-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CSCC\_ASC(22) | Cell therapy | 0.5 ml | Other |
| Subject | CSCC\_ASC(22) | Cell therapy | 11 cells | Other |